A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...

A new study has found a commonly prescribed anti-nausea medication is associated with better prognosis for women with early-stage breast cancer, particularly triple negative breast cancer.

Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy — ...

A new study out of the University of Minnesota's Hormel Institute looked at how dopamine can play a role in treating lung cancer. The study, published in the journal Cell Death & Disease, focused on ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than ...

New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...

Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.